Table 2.
Immunomodulatory molecules detected in CSCs/CICs
| Molecule | Functiona | Activity in CSCs/CICsb | Reference |
|---|---|---|---|
| IL-4 | Cytokine involved in differentiation of naïve T cells to Th2. | Inhibition of TH1 cell mediated immune responses. | [65, 118] |
| IL-10, IL-13 | Anti-inflammatory cytokines | Suppression of CTL functions; differentiation of Tregs and MDSCs | [89, 119] |
| TGFB | Growth factor with potent inhibitory function | Tregs differentiation, inhibition of TH1 responses | [89, 120] |
| STAT3 | Transcription factor with a potential anti-inflammatory function | Maintenance and proliferation of CSCs/CICs; differentiation of MDSCs, iDCs, M2 | [115, 121] |
| GDF15 | Growth and differentiation factor related to cellular stress. | Inhibition of anti-tumor immune responses | [122] |
| Galectin-3 | Protein with important role in cell-cell adhesion and interactions with the extracellular environment. | Inhibitor of T cell mediated immune responses | [89, 123] |
| IDO | Enzyme involved in tryptophan catabolism | Suppression of TH1 type immune responses and differentiation of Tregs. | [34, 51, 64, 65, 123] |
| CD200 | A glycoprotein that regulates myeloid cell activity and inhibits macrophage lineages. | Immune suppression and regulation of anti-tumor activity. | [124, 125] |
| PD-L1 | Ligand of PD-1 and Immune checkpoint molecule | Inhibition of CTL immune responses. | [64, 65, 126, 127] |
| B7-H3 and B7-H4 | Immune checkpoint molecules | Immunomodulation of cellular immune responses | [34, 64, 65, 128, 129] |
a: function of the molecules listed in the Table
b: Activity of these molecules when expressed by CSCs/CICs
iDC: suppressive dendritic cell; MDSC: Myeloid derived suppressive cells; M2: M2 phenotype of monocytes/macrophages; TH1: T helper type 1; TH2: T helper type 2